Table 2.
Pathological outcomes in both age groups
| Total N: 250 Median (IQR)-Mean (± SD) |
≤Age 70 (N: 182) | >Age 70 (N: 68) | p |
|---|---|---|---|
| Stage T | (N: 178) | (N: 66) | |
| T1 | 16 | 11 | 0.058 |
| T2 | 15 | 1 | |
| T3 | 58 | 15 | |
| T4 | 89 | 39 | |
| Stage N | (N: 180) | (N: 66) | |
| N0 | 46 | 22 | 0.648 |
| N1 | 25 | 7 | |
| N2 | 39 | 12 | |
| N3 | 70 | 25 | |
| Pathological Stage | |||
| Full Response | 3 | 0 | 0,305 |
| Stage I | 25 | 11 | |
| Stage II | 32 | 14 | |
| Stage III | 113 | 38 | |
| Stage IV | 9 | 5 | |
| Lymphovascular Invasion | (N: 180) | (N: 66) | |
| Yes | 148 | 52 | 0.342 |
| No | 32 | 14 | |
| Adjacent Organ Invasion | (N: 180) | (N: 66) | |
| Yes | 19 | 9 | 0,559 |
| No | 161 | 57 | |
| Peritoneal Cytology | (N: 106) | (N: 33) | |
| Positive | 24 | 13 | 0.057 |
| Negative | 82 | 20 | |
| Responses to Neoadjuvant | (N: 40) | (N: 7) | |
| Complete Response | 3 | 0 | 0.724 |
| Near Complete Response | 6 | 1 | |
| Partial Response | 10 | 3 | |
| Poor or No Response | 21 | 3 |
(SD: Standard Deviation, IQR: InterQuartile Range)